MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Clinical trial NCT07493538 · RECRUITING
Trial details
- NCT number
- NCT07493538
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2030-03-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.